Archive for neurology
Targeting synapse loss in Alzheimer’s to preserve cognition — before plaques appear
Currently, there are five FDA-approved drugs for Alzheimer’s disease, but these only boost cognition temporarily and don’t address the root causes of Alzheimer’s dementia. Many newer drugs in the pipeline seek to eliminate amyloid plaque deposits or reduce inflammation in the brain, but by the time this pathology is detectable, it’s unlikely medications can do much to slow ... Read More about Targeting synapse loss in Alzheimer’s to preserve cognition — before plaques appear
Immune cells “sculpt” brain circuits — by eating excess connections
The image above and the movie below show an immune cell caught in the act of tending the brain. The cell below has just eaten away unnecessary connections, or synapses, between neurons. That’s not something these cells, known as microglia, were previously thought to do. As immune cells, it was thought that their job was ... Read More about Immune cells “sculpt” brain circuits — by eating excess connections
Is rapamycin the new aspirin?
I’ve heard it said that if aspirin had to go through today’s FDA approval process, it would never be approved for over-the-counter use because it just does so many things. Lately, it’s been hard to cover biomedical research at Children’s without stumbling on another drug that’s also FDA-approved and also seems to have multiple uses: ... Read More about Is rapamycin the new aspirin?
The neurology resident that could
Elizabeth Engle used to wait in peoples’ driveways until midnight, hoping to enroll them in her genetic studies of eye-movement disorders. She landed there by chance: during her neurology residency, she saw a little boy whose eyes were frozen in a downward gaze. Wanting to find a solution to a disorder that others had written ... Read More about The neurology resident that could
Neurogenetic disorders: Dreaming the impossible dream
People with autism and most other disorders of brain development have never had medications to treat their core behavioral and cognitive symptoms. The best they can get are drugs targeting secondary problems, like irritability or aggression. But now, a new wave of clinical trials aims to change this. In the last decade, scientists have discovered ... Read More about Neurogenetic disorders: Dreaming the impossible dream